$KATX
KAT EXPLORATION, INC.

2022 Q3 Form 10-Q Financial Statement

#000168316822006669 Filed on September 29, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue $0.00 $0.00
YoY Change
Gross Profit $0.00 $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $10.00
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00 $0.00
YoY Change
% of Gross Profit
Operating Expenses $10.00 $38.50K $1.125K
YoY Change
Operating Profit -$10.00 -$38.50K -$1.125K
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00 $0.00
YoY Change
Pretax Income -$10.00 -$38.50K
YoY Change
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$10.00 -$38.50K -$1.125K
YoY Change
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 1.794B shares 1.794B shares 1.759B shares
Diluted Shares Outstanding 1.794B shares 1.794B shares 1.759B shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00
YoY Change
Cash & Equivalents $0.00 $0.00 $0.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $0.00
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $0.00
Total Long-Term Assets $0.00
Total Assets $0.00
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $0.00
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $17.64K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $17.64K
Total Long-Term Liabilities $0.00
Total Liabilities $17.64K
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$2.676M
YoY Change
Common Stock $1.794M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$17.64K -$17.63K -$14.13K
YoY Change
Total Liabilities & Shareholders Equity $0.00
YoY Change

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$10.00 -$38.50K -$1.125K
YoY Change
Depreciation, Depletion And Amortization $0.00 $0.00
YoY Change
Cash From Operating Activities -$35.00K $0.00
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 35.00K $0.00
YoY Change
NET CHANGE
Cash From Operating Activities -35.00K $0.00
Cash From Investing Activities $0.00
Cash From Financing Activities 35.00K $0.00
Net Change In Cash 0.000 $0.00
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$35.00K $0.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Small Business
EntitySmallBusiness
true
dei Entity File Number
EntityFileNumber
001-08589
dei Entity Registrant Name
EntityRegistrantName
KAT EXPLORATION, INC.
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
true
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1794271048 shares
CY2022Q3 us-gaap Cash
Cash
0 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001474558
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--11-30
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
usd
CY2020 us-gaap Net Income Loss
NetIncomeLoss
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-08-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-2737873
dei Entity Address Address Line1
EntityAddressAddressLine1
2313 Hollyhill Lane
dei Entity Address City Or Town
EntityAddressCityOrTown
Denton
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
76205
dei City Area Code
CityAreaCode
626
dei Local Phone Number
LocalPhoneNumber
429.2780
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021Q4 us-gaap Cash
Cash
0 usd
CY2022Q3 us-gaap Assets
Assets
0 usd
CY2021Q4 us-gaap Assets
Assets
0 usd
CY2022Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
17636 usd
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
13000 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
0 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
0 usd
CY2022Q3 us-gaap Liabilities
Liabilities
17636 usd
CY2021Q4 us-gaap Liabilities
Liabilities
13000 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1794271000 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1794271000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1759271048 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1759271048 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
1794271 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
1759271 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
864100 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
864100 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2676007 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2636371 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-17636 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-13000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 usd
CY2022Q3 us-gaap Revenues
Revenues
0 usd
CY2021Q3 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
10 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
0 usd
us-gaap Operating Expenses
OperatingExpenses
39636 usd
us-gaap Operating Expenses
OperatingExpenses
0 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-10 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
0 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-39636 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
0 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-10 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
0 usd
us-gaap Profit Loss
ProfitLoss
-39636 usd
us-gaap Profit Loss
ProfitLoss
0 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-10 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
0 usd
us-gaap Net Income Loss
NetIncomeLoss
-39636 usd
us-gaap Net Income Loss
NetIncomeLoss
0 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1794271048 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1794271048 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1759271048 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1759271048 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1794271048 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1794271048 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1759271048 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1759271048 shares
us-gaap Net Income Loss
NetIncomeLoss
-39636 usd
us-gaap Net Income Loss
NetIncomeLoss
0 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
4636 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
0 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-35000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
35000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
0 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
0 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-13000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-13000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1125 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-14125 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-38501 usd
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
35000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-17626 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-10 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-17636 usd
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1794271048 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1759271048 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1794271048 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1759271048 shares
CY2022Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
17636 usd

Files In Submission

Name View Source Status
0001683168-22-006669-index-headers.html Edgar Link pending
0001683168-22-006669-index.html Edgar Link pending
0001683168-22-006669.txt Edgar Link pending
0001683168-22-006669-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
katx-20220831.xsd Edgar Link pending
katx_ex3101.htm Edgar Link pending
katx_ex3102.htm Edgar Link pending
katx_ex3201.htm Edgar Link pending
katx_ex3202.htm Edgar Link pending
katx_i10q-083122.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
katx-20220831_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
katx-20220831_lab.xml Edgar Link unprocessable
katx-20220831_cal.xml Edgar Link unprocessable
katx-20220831_pre.xml Edgar Link unprocessable
katx_i10q-083122_htm.xml Edgar Link completed